Navigation Links
Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee

n or stepped doses leads to pain relief durable for 12 weeks in patients suffering from moderate to severe pain due to knee osteoarthritis.

The following table summarizes the reduction in pain scores provided by the use of Adlea compared to baseline pain scores. A scale of 0-4 (0 = no pain, 1 = mild pain, 2 = moderate pain, 3 = severe pain and 4 = extreme pain) was used in the study:

                                -- Weeks Following Adlea Treatment --


                       Baseline       1            8           12

                        (n=54)      (n=51)       (n=54)      (n=50)

    Average Pain

     Score               2.22        0.86         0.79        0.74


    Percentage

     Reduction from

     Baseline             N.A.         61%          64%         65%

How Adlea May Address Need for Long-Duration, Well-Tolerated Pain Relief

Adlea is long-acting, with the potential to provide pain relief for weeks or months after just a single localized treatment. It is a non-opioid TRPV1 agonist with a unique mechanism of action that provides a long-lasting, localized effect on C-fibers and blocks the transmission of aching, throbbing pain caused by major surgical procedures and end-stage osteoarthritis. Because it selectively acts on pain-sensing nerve endings, Adlea does not affect other nerve fibers necessary for sensory or motor sensations, such as those needed to sense temperature or pressure. In clinical studies to date, Adlea has not had the side effects often associated with other conventional pain medications and has been shown to be well tolerated.

Pharmacokinetic studies of Adlea showed that when it is locally administered to the site of pain, there appears to be limited systemic exposure. Its short duration of systemic exposure (hours) relative to the long duration of analgesia (12 weeks) resulting from a single treatment course of Adlea is particularly
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/2/2015)... Sept. 2, 2015  Research and Markets ( ... "An Introduction to the Medical Devices Directive ... to their offering. This seminar ... device legislation. It will explain the Directives and ... Bodies, how to choose one and outline what ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Therapeutic Drug ... their offering. This report deals with ... at improving patient care by monitoring drug levels ... of drugs for improving outcome. TDM is viewed ...
(Date:9/2/2015)... RATON, Fla. , Sept. 2, 2015 /PRNewswire-USNewswire/ ... , MD, FACS, has begun performing ultra-minimally invasive ... who are on anticoagulants such as Coumadin, Xarelto ... Cardiothoracic Surgery at the Hospital, is one of ... method, which involves making two microscopic incisions in ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3
... Urologists for Patient Access to Care (UPAC) today ... should no longer receive prostate-specific antigen (PSA) blood tests ... retrenchment in preventive health care." Dr. Scott ... care advocates to speak out to preserve prostate cancer ...
... Unity Management Group, Inc. (OTC: UYMG) "UNITY" (or ... Corporation (MCC), is proud to announce that they have ... subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA) for their patented ... excess of $50,000.00. MCC will be integrating their AIM ...
Cached Medicine Technology:Cancer Detection Tool Saves Lives 2Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA) 2Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA) 3
(Date:9/2/2015)... Newark, NJ (PRWEB) , ... September 02, 2015 , ... ... as Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) donated $11,000 to ... initial $5,000 donation to the foundation at the start of The Barclays, Horizon BCBSNJ ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Hydration ... allopathic medicine, opens its second location this week at 31542 S. Coast Hwy, ... feet of lounge space for patients to relax while receiving safe and effective ...
(Date:9/2/2015)... Appleton, WI (PRWEB) , ... September 02, 2015 ... ... Midwest, Cypress Benefit Administrators is taking action after seeing a significant ... The TPA’s Argus Claim Review division has found many cases of OON ASCs ...
(Date:9/2/2015)... KS (PRWEB) , ... September 02, 2015 , ... Amada ... its newest office in Kansas – its Johnson County location. Amada franchise ... healthcare. Mike has a registered nurse background and spent over 20 years in medical ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... imaging, content, records and case management solutions and services to both government and ... Image Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... ... market with the release of their new ReActive™ Court Surface. , ... Salt Lake City, Utah (PRWEB) February 7, 2010 -- ... primary advantage of the new system is its adherence to metric standards, while still utilizing ...
... translates to success on playing field, author says , FRIDAY. ... odds of becoming a professional athlete, a new study suggests. ... League (AFL) players and found that many were born in ... born in the later months. , The Australian school year ...
... ... offering plastic surgery in Phoenix . For women who are interested in enhancing the ... with breast implants. , ... AZ (Vocus) February 6, 2010 -- Over the course of his career, Dr. Steven Turkeltaub ...
... ... Possibilities And Cost Savings for the Funeral Home , ... Waunakee, WI (PRWEB) February 6, 2010 -- When you are saying ... At today’s funerals, you might hear the buzzword “personalization” but you might not be sure ...
... CHICAGO, Ill. (February 6, 2010) In a study to ... annual meeting, The Pregnancy Meeting , in Chicago, researchers will ... of intrauterine fetal death (IUFD), commonly known as stillbirth, in ... rare and affects only six to seven out of every ...
... ... their Creams N, Lotions Facebook page or followers of their Twitter handle, @100sheabutter. Five randomly ... , ... 5, 2010 -- Reforma Group is announcing a special Valentine,s Day giveaway to fans of ...
Cached Medicine News:Health News:SnapSports Releases ReActive Court Surfacing For The International Sports Market 2Health News:Kids Born Early in Year More Likely to Be Athletes? 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 3Health News:Frazer Consultants Riding the New Wave in Funeral Home Stationery 2Health News:Study finds higher risk of stillbirth in women with fibroids 2Health News:Romantic Valentine's Day Gift Ideas: Keep Your Skin Soft & Naughty Gift Basket Giveaway 2
Coat-A-Count PAP IRMA,is an immunoradiometric assay designed,for the quantitative measurement of,prostatic acid phosphatase (PAP) in,serum. It is intended strictly for in vitro,diagnostic u...
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
Medicine Products: